The demand for rubber gloves has been resilient after the H1N1 pandemic in 2009-2010, according to a new report from Research and Markets, Global Rubber Gloves Market: An Analysis - 2012." However, the industry is going to witness normalization in demand as there has been no major pandemic outbreak since last year. Although the industry has proved to be recession proof over the time, its growth mainly depends on the usage of gloves in the medical sector.Â
Malaysia remains the largest worldwide producer and exporter of rubber gloves at present and exports rubber gloves to the U.S., European Union, Latin America, China and India. The U.S., which is the largest glove importer, has been seeing an uptrend in total healthcare expenditure as percentage of GDP since 2000. The UK and major European countries are experiencing similar trends, and it is expected that other countries would raise their hygiene standards eventually.
Countries like India, China and Brazil have posted an increasing demand for rubber gloves in the recent past mainly because of the rising concerns related to health and hygiene in these regions. Demand for lower-end powdered latex gloves is popular among developing countries whose end-users are more cost-conscious. Powder-free latex and nitrile gloves are preferred by developed countries, namely the U.S. and European countries.
Latex is the major raw material required in manufacturing rubber gloves. Its price fluctuation becomes critical in determining the average selling price of glove. Other issues concerning to the industry, mainly to natural rubber glove producers, are continuous high volatility in latex price, a weaker U.S. dollar, and oversupply situation in the industry, resulting in a lower cost pass through to customers.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.